SecBot SecBot
6-K ·Filed Apr 21, 2026

GLAXF

GSK plc
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001654954-26-003750
Notable filing: 6-K
Actionable Insight • Neutral

Monitor the next quarterly filing for updates on the total buyback program expenditure and its impact on outstanding shares. The current repurchase is part of an ongoing program and does not signal a change in strategy.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -13.56% at T+60d
NEUTRAL call -13.56% · α vs SPY -20.46% · entry $29.50 → $25.50
Entry = T+0 close
Apr 21, 2026
via day close
T+1d
-7.76%
call -7.76% · α -8.78%
$27.21
settled 6mo ago
T+5d
-10.51%
call -10.51% · α -11.59%
$26.40
settled 6mo ago
T+20d
-12.88%
call -12.88% · α -17.80%
$25.70
settled 5mo ago
T+60d
-13.56%
call -13.56% · α -20.46%
$25.50
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

GSK plc repurchased 330,000 ordinary shares on April 20, 2026, at a volume-weighted average price of 2,141.19 GBp per share, as part of its existing buyback program. This brings the total repurchased under the program since February 17, 2026, to 20,186,521 shares.

Key Facts

  • GSK repurchased 330,000 ordinary shares on April 20, 2026.
  • The volume-weighted average price paid was 2,141.19 GBp per share.
  • The shares were purchased through BNP Paribas SA as part of a non-discretionary agreement.
  • Since February 17, 2026, GSK has purchased a total of 20,186,521 shares under this buyback program.
  • The repurchased shares will be held as treasury shares.

Financial Impact

The repurchase of 330,000 shares at an average price of 2,141.19 GBp represents a total expenditure of approximately £7.07 million.

dilution

Risk Factors

  • The buyback program may be subject to changes in market conditions or company strategy.
  • The actual impact on earnings per share will depend on the total number of shares repurchased and the program's completion.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003750
Document: 0001654954-26-003750-index-headers.html0001654954-26-003750
Document: 0001654954-26-003750-index.html0001654954-26-003750
Document: 0001654954-26-003750.txt0001654954-26-003750
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Open — Closes in 6h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026